Does RITUXAN Cause Progressive multifocal leukoencephalopathy? 8 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Progressive multifocal leukoencephalopathy have been filed in association with RITUXAN. This represents 1.6% of all adverse event reports for RITUXAN.
8
Reports of Progressive multifocal leukoencephalopathy with RITUXAN
1.6%
of all RITUXAN reports
1
Deaths
3
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From RITUXAN?
Of the 8 reports, 1 (12.5%) resulted in death, 3 (37.5%) required hospitalization, and 2 (25.0%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXAN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXAN Cause?
Arthralgia (39)
Death (37)
Drug ineffective (37)
Off label use (34)
Infusion related reaction (33)
Pyrexia (33)
Dyspnoea (30)
Nausea (26)
Fatigue (25)
Rash (24)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which RITUXAN Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
RITUXAN vs RITUXIMAB
RITUXAN vs RITUXIMAB-ABBS
RITUXAN vs RITUXIMAB-ARRX
RITUXAN vs RITUXIMAB-PVVR
RITUXAN vs RIVAROXABAN